Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

MedX Health Corp

Healthcare CA MDX

0.055CAD
0.00(0%)

Last update at 2026-06-04T13:30:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.050.10
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap18.04M
  • Volume3900
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.38591M
  • Revenue TTM0.52M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.18M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -3.65297M -4.58055M -5.13370M -5.32354M -3.19948M
Minority interest - - - - -
Net income -3.65297M -4.58055M -5.13370M -5.32354M -3.19948M
Selling general administrative 1.67M 2.22M 2.94M 3.55M 2.79M
Selling and marketing expenses - - - - -
Gross profit 0.19M 0.19M 0.24M 0.29M 0.27M
Reconciled depreciation 0.05M 0.05M 0.05M 0.05M 0.08M
Ebit - - - - -3.02942M
Ebitda - - -3.81329M -4.49412M -3.06185M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -2.30375M -3.02836M -3.86838M -4.56275M -3.02942M
Other operating expenses - - - - -
Interest expense 1.35M 2.15M 1.27M 0.78M 0.06M
Tax provision - - - - -
Interest income - - - - -
Net interest income -1.34922M -2.15000M -1.26872M -0.77761M -0.05817M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.49M 0.46M 0.51M 0.56M 0.53M
Total operating expenses 2.79M 3.48M 4.38M 5.13M 3.56M
Cost of revenue 0.30M 0.27M 0.27M 0.27M 0.26M
Total other income expense net - 0.60M 0.00340M 0.02M -0.11188M
Discontinued operations - - - - -
Net income from continuing ops -3.65297M -4.58055M -5.13370M -5.32354M -3.19948M
Net income applicable to common shares - - - - -3.19948M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.88M 0.69M 0.68M 0.73M 0.73M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 9.41M 7.83M 7.76M 4.36M 2.80M
Total stockholder equity -8.52410M -7.14185M -7.08098M -3.63042M -2.07011M
Deferred long term liab - - - - -
Other current liab - - - 0.62M 0.59M
Common stock - - - - 23.00M
Capital stock 27.49M 26.95M 23.96M 23.94M 23.00M
Retained earnings -54.50270M -50.84973M -46.26918M -41.13548M -35.81194M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.16M 0.14M 0.14M 0.11M 0.04M
Cash and equivalents - - - - -
Total current liabilities 8.33M 6.95M 6.88M 1.97M 2.57M
Current deferred revenue - - - - -
Net debt 6.82M 5.62M 4.86M 2.47M 0.88M
Short term debt - - - - -
Short long term debt 5.90M 4.91M 4.12M 0.19M 0.68M
Short long term debt total - - - - -
Other stockholder equity - - - - 2.41M
Property plant equipment - - - - 0.22M
Total current assets 0.84M 0.60M 0.54M 0.54M 0.51M
Long term investments - - - - -
Net tangible assets - - - - -2.07011M
Short term investments - - - - -
Net receivables 0.03M 0.00770M 0.00820M 0.00963M 0.04M
Long term debt 1.08M 0.84M 0.88M 2.39M 0.23M
Inventory 0.38M 0.34M 0.38M 0.37M 0.37M
Accounts payable 0.34M 0.63M 0.62M 0.50M 0.56M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.04M 0.09M 0.14M 0.19M 0.22M
Capital lease obligations 0.04M 0.09M - - 0.03M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.00000M 0.00000M 0.00000M -0.01649M -0.00550M
Change to liabilities - - - 0.00000M -0.12661M
Total cashflows from investing activities - - - - -0.00550M
Net borrowings 2.10M 2.95M - - -0.04364M
Total cash from financing activities 2.53M 3.42M 2.84M 4.60M 2.94M
Change to operating activities - - - - -0.00936M
Net income -3.65297M -4.58055M -5.13370M -5.32354M -3.19948M
Change in cash 0.02M -0.00431M 0.04M 0.07M 0.03M
Begin period cash flow 0.14M 0.14M 0.11M 0.04M 0.01M
End period cash flow 0.16M 0.14M 0.14M 0.11M 0.04M
Total cash from operating activities -2.51068M -3.42214M -2.80084M -4.51671M -2.90887M
Issuance of capital stock 0.43M 0.41M 0.00000M 0.93M 2.98M
Depreciation 0.05M 0.05M 0.05M 0.05M 0.08M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.03990M 0.16M -0.00567M 0.00055M -0.13379M
Change to account receivables -0.02184M -0.06125M -0.13444M -0.03130M 0.02M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - 0.22M 0.22M
Change to netincome - - - - 0.46M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.02M 0.00550M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.19M -0.12918M 1.02M 0.04M -0.25814M
Stock based compensation 0.14M 0.31M 0.33M 0.23M 0.35M
Other non cash items 1.35M 2.12M 1.27M 0.51M 0.02M
Free cash flow -2.51068M -3.42214M -2.80084M -4.53320M -2.91437M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MDX
MedX Health Corp		 - -% 0.06 - 13.50 34.49 - 53.75 -3.7833
TLT
Theralase Technologies Inc.		 0.01 4.44% 0.23 - - 90.07 82.51 90.31 -12.0585
CNVI
Conavi Medical Corp.		 -0.025 9.09% 0.25 - - 66.65 - 95.30
PINK
Perimeter Medical Imaging AI Inc		 -0.015 4.55% 0.32 4.13 - 18.78 11.34 20.22 -2.5521
CHER
Cheelcare Inc.		 - -% 1.65 - - 20.92 106.42 21.26

Reports Covered

Stock Research & News

View All

Profile

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also provides scope kits, SIAscope, a clinical camera; and DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.

MedX Health Corp

1495 Bonhill Road, Mississauga, ON, Canada, L5T 1M2

Key Executives

Name Title Year Born
Mr. Louie Canitano COO & MD of Light Therapy Products NA
Mr. Michael Druhan Pres of Dermatological Services & Products NA
Mr. Naman Demaghlatrous BAMA Pres, CEO & Director NA
C H Freeman Interim Chief Financial Officer NA
Mr. Paul Karam Sales and Marketing Director of Europe, Middle East & Africa NA
Dr. Daniel A. Kaute Managing Director of Europe NA
Mr. Scott Naughton Managing Director of US Operations NA
Mr. Christopher H. Freeman Sec. NA
Mr. Christopher H. Freeman Corporate Secretary & Acting CFO NA
Mr. Michael Druhan President of Dermatological Services & Products NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions